311 results on '"Villanueva, Vicente"'
Search Results
2. Perampanel for Treatment of People with a Range of Epilepsy Aetiologies in Clinical Practice: Evidence from the PERMIT Extension Study
3. Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysis
4. Clinical and economic implications of epilepsy management across treatment lines in Spain: a real-life database analysis
5. Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records
6. Patient profile, management, and quality of life associated with Dravet syndrome: a cross-sectional, multicentre study of 80 patients in Spain
7. Brivaracetam effectiveness and tolerability in older and younger adults with epilepsy: EXPERIENCE, a pooled analysis of international data from retrospective studies
8. Perampanel for the treatment of epilepsy with genetic aetiology: Real-world evidence from the PERMIT Extension study
9. Proposed Recommendations for the Management of Depression in Adults with Epilepsy: An Expert Consensus
10. The relationship between memory and quality of life is mediated by trait anxiety in patients with temporal lobe epilepsy
11. Impact of antiseizure medication with a very long half-life on long term video-EEG monitoring in focal epilepsy
12. Antiseizure medications (antiepileptic drugs) in adults: starting, monitoring and stopping
13. Real-life evidence about the use of intravenous brivaracetam in urgent seizures: The BRIV-IV study
14. Effectiveness, safety and tolerability of perampanel by age group when used to treat people with focal and generalized epilepsy in clinical practice: The PERMIT Extension study
15. Retrospective chart review study of use of cannabidiol (CBD) independent of concomitant clobazam use in patients with Lennox-Gastaut syndrome or Dravet syndrome
16. Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain
17. Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsy
18. PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice
19. Assessment of the long-term efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of open-label extension studies
20. Perampanel for the treatment of patients with myoclonic seizures in clinical practice: Evidence from the PERMIT study
21. Clinical utility of Epitrack for differentiating profiles and patterns of post-surgical change in memory and quality of life in patients with drug-resistant epilepsy.
22. Therapeutic strategies during cenobamate treatment initiation: Delphi panel recommendations.
23. Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug‐resistant focal seizures.
24. Impact of Polytherapy on Memory Functioning in Patients With Drug-Resistant Epilepsy: The Role of Attention and Executive Functions.
25. Identifying key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through Multi-Criteria Decision Analysis (MCDA)
26. Predictors of seizure freedom, response and retention after 12 months of treatment with eslicarbazepine acetate: A post-hoc analysis of the Euro-Esli study
27. Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review
28. Complementary and alternative medicine in epilepsy: A global survey of physicians’ opinions
29. The number of anti-seizure medications mediates the relationship between cognitive performance and quality of life in temporal lobe epilepsy
30. Initiating antiepilepsy treatment: An update of expert consensus in Spain
31. Involvement of mental health professionals in the treatment of tuberous sclerosis complex–associated neuropsychiatric disorders (TAND): results of a multinational European electronic survey
32. Safety, tolerability and effectiveness of transition to eslicarbazepine acetate from carbamazepine or oxcarbazepine in clinical practice
33. Multichannel dynamic modeling of non-Gaussian mixtures
34. Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study
35. Eslicarbazepine acetate in epilepsy patients with psychiatric comorbidities and intellectual disability: Clinical practice findings from the Euro-Esli study
36. Quality of life in drug-resistant epilepsy: relationships with negative affectivity, memory, somatic symptoms and social support
37. Prospective study of cenobamate on cognition, affectivity, and quality of life in focal epilepsy.
38. Dibenzazepine Agents in Epilepsy: How Does Eslicarbazepine Acetate Differ?
39. VERTICO and IllustrisTNG: The Spatially Resolved Effects of Environment on Galactic Gas.
40. Candidate Selection for Implantation: Noninvasive Predictors of Seizure Onset Zone Focality and Surgical Outcome in People with Drug-Resistant Epilepsy Evaluated by Intracranial Video-EEG Monitoring—A Retrospective Cohort Study.
41. Real‐world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program.
42. The EDGE-CALIFA Survey: Spatially Resolved 13 CO(1–0) Observations and Variations in 12 CO(1–0)/ 13 CO(1–0) in Nearby Galaxies on Kiloparsec Scales.
43. Pharmacokinetics, exposure–cognition, and exposure–efficacy relationships of perampanel in adolescents with inadequately controlled partial-onset seizures
44. Euro-Esli: a European audit of real-world use of eslicarbazepine acetate as a treatment for partial-onset seizures
45. A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report
46. Perampanel for the treatment of people with idiopathic generalized epilepsy in clinical practice.
47. Stress phenotypes in epilepsy: impact on cognitive functioning and quality of life.
48. Initial monotherapy with eslicarbazepine acetate for the management of adult patients with focal epilepsy in clinical practice: a meta-analysis of observational studies.
49. Perampanel outcomes at different stages of treatment in people with focal and generalized epilepsy treated in clinical practice: Evidence from the PERMIT study.
50. VERTICO: III. The Kennicutt-Schmidt relation in Virgo cluster galaxies.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.